{"id":"W1989987919","doi":"10.1007/s10637-006-5938-1","title":"Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study","year":2006,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pyrogenesis (Canada); Queen's University; London Health Sciences Centre; Hôpital Notre-Dame; Princess Margaret Cancer Centre; University Health Network; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Medical Research Council; University Health Network","keywords":"Clinical trial; Medicine; Renal cell carcinoma; Cancer; Phases of clinical research; Drug; Oncology; Cancer drugs; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001332266,0.001816969,0.00302056,0.0006315202,0.000624846,0.001089617,0.001306071,0.001769088,0.003257233],"category_scores_gemma":[0.001094896,0.0006367384,0.001493469,0.0007117324,0.001147619,0.0008314418,0.0003573474,0.003623484,0.0006589172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001782103,"about_ca_system_score_gemma":0.002737392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00682263,"about_ca_topic_score_gemma":0.01849846,"domain_scores_codex":[0.9995682,0.0002001111,0.00001494495,0.00006471273,0.00004086117,0.000111186],"domain_scores_gemma":[0.9991474,0.0001695063,0.0001265848,0.00005809589,0.0000482343,0.0004500703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7898446,0.04182525,0.007683038,0.000679557,0.001407008,0.0003779665,0.00036916,0.004871063,0.0351129,0.0006307121,0.007227986,0.1099708],"study_design_scores_gemma":[0.6726611,0.3076025,0.01068784,0.00003316238,0.0004255932,0.0002170695,0.0001019924,0.001767051,0.003509206,0.0003032532,0.002647931,0.00004337462],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904612,0.002888219,0.0004819217,0.001211901,0.0002482379,0.001403015,0.001175372,0.00009320096,0.002037024],"genre_scores_gemma":[0.9864429,0.003334529,0.001543563,0.001081561,0.0002382748,0.001533627,0.00202149,0.00004564997,0.003758353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00682263,"threshold_uncertainty_score":0.01356578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03687109437820722,"score_gpt":0.3202348674483818,"score_spread":0.2833637730701745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}